Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder, BlueOcean Ventures SA is based in Geneva, Switzerland, and registered in Jersey. The firm focuses on early-stage investments in medical devices and life sciences, managing a portfolio of 12 companies. It typically invests in companies with pre-money valuations between CHF 3 to 10 million.
BlueOcean Ventures primarily targets early-stage medical device and diagnostics companies in Switzerland and Europe. The firm also invests in life sciences, digital health, and nanotechnologies. As a lead investor or co-investor, it seeks to support startups with significant growth potential.
Notable portfolio companies include Mikajaki SA, which develops automated cyanide monitoring solutions, and Luciole Medical AG, known for its RheoPatch product. Other investments include Volumina Medical SA, Ava, DistalMotion, Abionic SA, AIMAGO SA, MYOPOWERS MEDICAL TECHNOLOGIES SA, ANERGIS SA, VIROBLOCK SA, AUGURIX SA, SENSIMED SA, and Rheon Medical SA.
Submit your pitch through their form at blueocean-ventures.com.
Yes, BlueOcean Ventures often acts as a lead investor or co-investor in funding rounds, particularly for promising startups.
The firm is open to follow-on investments, especially in companies that demonstrate significant growth potential and align with their investment thesis.
Specific fund size details are not disclosed, but the firm typically invests in companies with pre-money valuations ranging from CHF 3 to 10 million.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.